Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. - Wikidata - awgldk - TriplyDB

Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels.

Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels.

http://www.wikidata.org/entity/Q37067149

about

A Molecular and Whole Body Insight of the Mechanisms Surrounding Glucose Disposal and Insulin Resistance with Hypoxic Treatment in Skeletal Muscle Dysglycemia after renal transplantation: Definition, pathogenesis, outcomes and implications for management Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States Identification of differential responses to an oral glucose tolerance test in healthy adults Uncovering Factors Related to Pancreatic Beta-Cell Function Evaluation of fasting state-/oral glucose tolerance test-derived measures of insulin release for the detection of genetically impaired β-cell function Exercise Intensity Modulates Glucose-Stimulated Insulin Secretion when Adjusted for Adipose, Liver and Skeletal Muscle Insulin Resistance.Obstructive sleep apnea in young lean men: impact on insulin sensitivity and secretion Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study.Lifestyle and Metformin Ameliorate Insulin Sensitivity Independently of the Genetic Burden of Established Insulin Resistance Variants in Diabetes Prevention Program Participants Pancreatic adipose tissue infiltration, parenchymal steatosis and beta cell function in humans.Physical activity, sedentary behaviors, and estimated insulin sensitivity and secretion in pregnant and non-pregnant women.Effect of vitamin D supplementation on oral glucose tolerance in individuals with low vitamin D status and increased risk for developing type 2 diabetes (EVIDENCE): A double-blind, randomized, placebo-controlled clinical trial.The influence of rare genetic variation in SLC30A8 on diabetes incidence and β-cell function.Fasting serum taurine-conjugated bile acids are elevated in type 2 diabetes and do not change with intensification of insulin Age-dependent decline in β-cell function assessed by an oral glucose tolerance test-based disposition index.β-Cell failure in type 2 diabetes.Concordance of bioactive vs. total immunoreactive serum leptin levels in children with severe early onset obesity Post-meal β-cell function predicts the efficacy of glycemic control in patients with type 2 diabetes inadequately controlled by metformin monotherapy after addition of glibenclamide or acarbose More Favorable Metabolic Impact of Three-Times-Weekly versus Daily Growth Hormone Treatment in Naïve GH-Deficient Children Childhood Maltreatment Is an Independent Risk Factor for Prediabetic Disturbances in Glucose Regulation.Plasma mannose level, a putative indicator of glycogenolysis, and glucose tolerance in Japanese individuals.Plasma 25-hydroxyvitamin D and risk of metabolic syndrome: an ancillary analysis in the Diabetes Prevention Program.Disposition index, glucose effectiveness, and conversion to type 2 diabetes: the Insulin Resistance Atherosclerosis Study (IRAS)Oral glucose tolerance test-based calculation identifies different glucose intolerance phenotypes within the impaired fasting glucose range Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program.Stress hyperglycaemia in critically ill patients and the subsequent risk of diabetes: a systematic review and meta-analysis Updated genetic score based on 34 confirmed type 2 diabetes Loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program.Etiology of insulin resistance in youth with type 2 diabetes Insulin resistance in type 2 diabetic youth Kidney function, β-cell function and glucose tolerance in older men.Effect of phosphodiesterase inhibition on insulin resistance in obese individuals.Rapid deterioration of insulin secretion in obese adolescents preceding the onset of type 2 diabetes.Declining β-cell function relative to insulin sensitivity with escalating OGTT 2-h glucose concentrations in the nondiabetic through the diabetic range in overweight youth.Glucose effectiveness in obese children: relation to degree of obesity and dysglycemia.Effect of vildagliptin on hepatic steatosis.Triglyceride response to an intensive lifestyle intervention is enhanced in carriers of the GCKR Pro446Leu polymorphism Normal Glucose Tolerance with a High 1-Hour Postload Plasma Glucose Level Exhibits Decreased β-Cell Function Similar to Impaired Glucose Tolerance Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT.Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism

P2860

Q26747591-2EBBC938-E30F-419F-AB6B-AE24FF23F771 Q26795773-B1F3CAED-A425-4FB1-8FCE-08A636011BEE Q26859746-42E7C5F9-D0B7-4EA8-86DE-61BA2CCEC856 Q28535572-295F9623-FCF9-4548-9019-2A77D7D21427 Q28553583-5E094CC3-57BF-4D9C-8C1A-AE1C67538FEB Q28744489-464ACD85-96D1-40AC-964C-EE277C1024CA Q30276917-DE0A1E96-7DBE-42CE-97C3-3422BDCE639A Q30447694-D36AAFB6-FDF5-477E-A471-807E4308E61B Q30533186-0443B4FE-26C6-4C82-BE46-1B188E015552 Q30708887-5397765A-F8E8-4A59-8BDA-E89CF09C6393 Q30903914-414A8488-02CB-4703-8373-E2C5C933B282 Q31018690-9599E5C7-55DE-47C7-B8E0-C246C0BACDCA Q33390806-3B408365-4A99-4D7E-97DC-C4E6C35B5716 Q33568942-CA0A628D-D8F8-4D63-8A35-CDE05D157D4E Q33570050-1FDA94BC-9739-4EF5-B28F-BE183A4EEFA9 Q33585867-9A19CBFC-8CE9-4A5C-9C65-F35A0FEFB3E4 Q33588325-556624E6-FE2A-4842-B42D-C6615D7E9371 Q33718974-72326DC9-803A-4EBD-A9BE-3107FE427A59 Q33756059-EF1A9DAC-9385-4850-BAE8-02948CC9774B Q33786906-085646E2-2146-45C2-AB4E-D790691D122A Q33857423-825377A5-7A7C-4ACE-881F-6FD5725235DF Q33871284-5648DDE4-5686-4687-9542-D694CED9301C Q33881452-41402B20-77D6-4C6E-AFE3-54FAB4252D9E Q34084640-2C1147F4-994F-4254-AED9-296DE985AEDB Q34299634-5B71FAA6-714C-4C40-A3D1-3D037E8C1805 Q34415887-79EDC1D9-8208-47DC-93F0-6E1B9AE84B03 Q34541305-6C54279D-54DC-4B01-B197-57930C043A29 Q34718943-84563726-802B-440C-BC51-6670A2B7CE75 Q34974105-3CA2DC41-9320-4682-8E55-A9BAAB5B2BE1 Q34974110-0D87AF5C-590A-4B36-94C8-11EB2B560F53 Q35055095-907AFDAD-1640-49C4-A5F5-AA63F7AB9570 Q35070707-88A53982-8B67-45B9-B263-B089F27F5D7D Q35132429-44F17CB9-8E7B-487F-9A18-138AA3060CA9 Q35179833-D6C31741-7194-47F9-8146-E78042933D16 Q35207924-9B92BE80-2530-456A-9DFA-4B5B80BEB60E Q35442079-98E6710F-C812-4D01-8B17-210D0AD64980 Q35493159-FBFDAC27-7CB6-4AC4-9C6D-8122EFDC93CF Q35544026-E0C9A0C0-40AA-4D44-942A-59C6B5C972E8 Q35797022-24556EFD-B52E-44F0-B00D-4A114B12F2D4 Q35839938-39DBDB34-CB65-4AAF-BA17-BDBE1BB39F3E

P2860

Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels.

http://www.wikidata.org/entity/Q37067149

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 October 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Oral disposition index predict ...... asting and 2-h glucose levels.

@en

Oral disposition index predict ...... asting and 2-h glucose levels.

@nl

type

label

Oral disposition index predict ...... asting and 2-h glucose levels.

@en

Oral disposition index predict ...... asting and 2-h glucose levels.

@nl

prefLabel

Oral disposition index predict ...... asting and 2-h glucose levels.

@en

Oral disposition index predict ...... asting and 2-h glucose levels.

@nl

P1433

Q37067149-32568B4E-F557-4406-BED7-B347BA761B5A

P1476

Q37067149-07730953-67F6-482D-B498-D22AFC7EAD9C

P2093

Q37067149-0FFC8371-9C0C-469A-9D6C-7C3BE9F3567F

Q37067149-33A32DA7-E89E-4938-BB9C-9664702A3BF6

Q37067149-39DEFB5C-0055-42FD-8DE6-FF1BF356CAEF

Q37067149-601B771E-3B10-43AB-8D33-784798E83EFF

Q37067149-6589B77A-3D25-41B8-ACE1-45A8148102F5

Q37067149-6DD93FF9-E3A1-4921-B84C-EA59E808E1E6

Q37067149-AD657A3D-C1E7-45C8-BD07-292430B0CB42

Q37067149-CFC87887-FE3E-44DD-962E-58082DC856A1

P2860

Q37067149-0CA3AD6E-8F37-4419-8F5D-630B54A8F4BB

Q37067149-1461EED3-C539-4C9A-BE16-182D71F0FA90

Q37067149-16245ED1-5FA8-434D-B4FB-5BCABDC5A0F0

Q37067149-1E0C39F5-103F-4916-809B-EDEE6B1F5561

Q37067149-336CB3F8-F59D-46A1-A7AB-5E9BB504EF5E

Q37067149-3CCE6B2F-4B4B-427F-8E76-78378E7093FA

Q37067149-460BAA34-54C8-4E31-907F-14015F8F93F7

Q37067149-49AC0E67-FDC5-4BE1-BE11-08F0EAFF8675

Q37067149-4DBE3480-92FE-4CE2-B905-B98AFDDC16E2

Q37067149-5013155E-23E8-43D4-A7AB-DDA9A6BFFE76

P304

Q37067149-57005D51-6AC9-4C19-BB40-E4DEC901556A

P31

Q37067149-103D1B0F-E662-45FA-B47A-58938A81A24F

P356

Q37067149-8BBF3E9B-8480-4132-9E28-31693F946A86

P407

Q37067149-645CAF5A-3D99-4424-8DD7-D16B3848AADC

P433

Q37067149-95598749-2F3A-4CE0-8892-CB6C2A54982A

P478

Q37067149-C728C3EB-826F-4EFA-AE06-3FFDB780FD48

P50

Q37067149-91CF5E4A-EAD5-4063-90A5-D2ABBFFC25F4

Q37067149-F2F236F5-2852-42F4-B1F2-72BEE68F9D50

P577

Q37067149-599A7761-9110-4705-8F38-81993E078F96

P5875

Q37067149-0137B944-8BD7-4589-9D44-3D5E634F1509

P698

Q37067149-84A19CD1-8F5C-4F10-908A-8022E2027DE3

P921

Q37067149-454d70af-40ef-401c-bb09-009eb0c562d6

Q37067149-93E01A00-229A-4DB9-9E1B-B4479DFC7673

P932

Q37067149-49E99153-91D8-4CCB-87A6-E2414A201991

P356

P1433

P1476

Oral disposition index predict ...... asting and 2-h glucose levels.

@en

P2093

Darcy B Carr

http://www.w3.org/2001/XMLSchema#string

Donna L Leonetti

http://www.w3.org/2001/XMLSchema#string

Jenny Tong

http://www.w3.org/2001/XMLSchema#string

Kristina M Utzschneider

http://www.w3.org/2001/XMLSchema#string

Marguerite J McNeely

http://www.w3.org/2001/XMLSchema#string

Mirjam V Faulenbach

http://www.w3.org/2001/XMLSchema#string

Ronald L Prigeon

http://www.w3.org/2001/XMLSchema#string

Wilfred Y Fujimoto

http://www.w3.org/2001/XMLSchema#string

P2860

Correct homeostasis model assessment (HOMA) evaluation uses the computer program

Estimation of beta-cell function from the data of the oral glucose tolerance test.

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus.

Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.

The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.

Follow-up report on the diagnosis of diabetes mellitus.

TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program

Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.

Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose.

Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes.

P304

335-341

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC08-1478

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Edward J. Boyko

P577

2008-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23425227

http://www.w3.org/2001/XMLSchema#string

P698

18957530

http://www.w3.org/2001/XMLSchema#string

P921

P932

2628704

http://www.w3.org/2001/XMLSchema#string